Considering the reports described above, we decided to investigate the effects of both ceragenin CSA-13 and its magnetic nanoparticle-based derivative, MNP@CSA-13, on breast cancer cells lines that are known to increase their growth upon stimulation by human cathelicidin LL-37. Here, CAMP is linked to breast carcinoma.